REGENXBIO (NASDAQ:RGNX) Earnings Information
REGENXBIO last posted its earnings data on February 28th, 2021. The biotechnology company reported ($1.24) earnings per share for the quarter, missing the consensus estimate of $1.11 by $2.35. The company had revenue of $21.40 million for the quarter, compared to the consensus estimate of $61.57 million. Its revenue for the quarter was up 81.4% on a year-over-year basis. REGENXBIO has generated ($3.26) earnings per share over the last year. REGENXBIO has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 6th, 2021 based off prior year's report dates.
REGENXBIO Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
REGENXBIO (NASDAQ:RGNX) Earnings Estimates
2021 EPS Consensus Estimate: ($3.71)
REGENXBIO (NASDAQ RGNX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)